Australian Doctor Australian Doctor 17th November 2017 | Page 3
RACHEL WORSLEY
A DOCTOR has lost a nine-
month legal fight to keep
practising after she claimed
she was unfairly suspended
under the NSW Medical
Council’s emergency pow-
ers.
Dr Denise Jane Lee, a
radiologist based in Syd-
ney, was banned after being
charged with stalking her
former partner, his new girl-
friend and the girlfriend’s
parents through text mes-
sages and emails.
The criminal allegations,
which Dr Lee denies, were
unrelated to her clinical
work and she was no threat
to patients.
But in February, the coun-
cil suspended her by using its
section 150 “public interest”
emergency powers. It stated
that she posed a “significant
risk and had acted in ways
that damage the standing of
the medical profession”.
In September, Dr Lee suc-
Newspix
Radiologist loses 9-month fight
In Brief
Staff writers
Change in the air for
COPD inhaler guidelines
Dr Lee denies the criminal
allegations, which are
unrelated to her clinical work.
cessfully appealed to the
NSW Civil and Adminis-
trative Tribunal to lift the
suspension so she could
fund her living expenses and
defence of criminal charges.
The tribunal said Dr Lee
was entitled to the presump-
tion of innocence, ruling
that her competence as a
radiologist was not an issue
and there was “no real risk
to patients or the public”.
But the NSW Court of
Appeal reinstated the sus-
pension, finding that only
the medical council, not the
tribunal, had the power to
lift the suspension. “The
[medical] council is best
placed to assess whether the
interim measure of suspend-
ing the registration should
remain in place, having
regard to the health and
safety of the public,” the
court said.
The ruling stressed that
the tribunal could only
overturn the medical coun-
cil’s suspension if the case
related to a point of law.
Dr Lee was immediately
suspended again after the
court’s ruling was handed
down last week.
PBS restrictions on COPD
inhalers may be eased
to align with the Lung
Fdoundation’s COPD-X
guidelines. The guidance
recommends fixed-dose
combination inhalers of
long-acting muscarinic
antagonists (LAMA) and
LABAs for patients who
remain symptomatic
despite monotherapy
with either. The
Pharmaceutical Benefits
Advisory Committee
recommends removing
the current requirement to
stabilise patients on both
individual monotherapy
inhalers before initiating
the combinations. It also
recommends an increased
restriction to authority
required (streamlined) for
inhaled corticosteroid/
LABA inhalers to counter
high rates of initiation.
Doctors denied presumption of innocence
Comment
Rachel Worsley
THE ruling in the Dr Denise Lee case
is significant. Medical boards use their
emergency powers to suspend doctors
to protect the public from potential
harm while serious concerns about
an individual’s practice are properly
investigated. At least that is the general
idea.
Yet the use of those powers in NSW
have been controversial. Medical
defence organisations argue that the
powers are so broad that doctors can
be unfairly banned from practising,
even when they present no immediate
threat to public safety.
The legislation underpinning section
150 of the National Law in NSW says
a suspension can be instituted for the
protection of a person or people, and
also when it is deemed “in the public
interest”.
Obviously public interest has a very
broad definition and can mean many
different things to different people.
This has all been made explicit in Dr
Lee’s case. Her lawyers argued that the
alleged criminal behaviour doesn’t pose
an immediate threat to public safety.
When the original ban on her
practice was briefly lifted, it was
done so because the NSW Civil and
Administrative Tribunal said Dr Lee had
not been convicted of the charges, and
she was entitled to a presumption of
innocence.
The tribunal also noted that Dr Lee’s
medical competence was not at issue.
In throwing out that determination,
the appeal court has made it clear that
doctors in NSW have severely limited
rights to appeal if they are suspended
by the medical council under
emergency powers.
Put simply, the appeal court said
there is no independent avenue for
doctors to appeal the use of these
powers — unless it relates to a point
of law. In other words, the facts of the
case are irrelevant.
Given that under these emergency
powers suspensions can run for
months — in Dr Lee’s case more
than eight months — their use has a
profound impact on a doctor’s ability to
continue earning a living.
There is a twist, though. This
situation is no longer unique to NSW.
Following amendments to the
National Law earlier this year, the
powers to suspend doctors on the
basis of “public interest” (rather than
immediate threat to the public) are now
in effect across all states and territories
except SA and WA. However these
states are expected to pass their own
laws to effect the changes.
MDOs such as Avant have previously
expressed concerns that the public
interest powers in NSW are no longer
being employed only in exceptional
circumstances. “These powers are
being used as a matter of course in an
investigation when there’s a complaint
made,” Avant head of advocacy
Georgie Haysom said.
The question is whether this starts
to happen in other states and whether
there are similar limitations on doctors’
ability to get justice if they believe they
are being misused.
Slip, Slop, Slap a
success
PUBLIC health campaigns
on skin cancer prevention
have resulted in a sharp
decline in melanoma rates
among people born after
1980, research from Cancer
Council Queensland shows.
Melanoma incidence
continues to be high among
people over 60, however
it has declined in younger
age groups, according to
figures from 1995-2014.
Modest Minister Hunt says May budget will be
remembered as a ‘foundational moment’
GEIR O’ROURKE
Health Minister Greg Hunt is impressed with his work thus far.
HEALTH minister Greg Hunt
says his first budget in the
portfolio will one day be seen
as a “foundational moment” in
the history of Australia’s health
system.
Writing in the Medical
Journal of Australia, Mr Hunt
argues that his achievements
since taking over from Sussan
Ley in January have laid the
groundwork for “long-term,
generational change”.
Among what he cites as his
major victories is “returning
indexation of the Medicare
rebate”, without mentioning
that it was his government
which took it away in the first
place.
Most GPs are also aware
that the Medicare windfall
has yet to happen — the 50c
expected increase to a level B
consult only occurs next July,
while the increases for MBS
care plans will not occur until
2020.
But the minister says the
financial boost “makes it
easier to bulk-bill and reduces
patients’ out-of-pocket
expenses”.
“The budget handed
down in May 2017 reset the
health agenda,” he declared.
“I believe it will come to
represent a foundational
moment in building a health
system for 21st century
Australia, anchored on our
www.australiandoctor.com.au
commitment to universal
healthcare based on free
public hospital care, affordable
medical services and
affordable medicines.”
Mr Hunt identified private
health insurance, mental
health, sport and aged care as
his top priorities for next year.
Primary care and hospitals,
under his “wave three”
reforms, will be his focus in
2019.
Health Care Homes, which
Mr Hunt’s predecessor once
described as the biggest
reform to general practice
since the advent of Medicare,
rated a mention near the
bottom of the MJA essay.
EpiPen shortage advice
A SHORTAGE of EpiPen
Jr 150µg autoinjectors is
expected to be resolved by
late November, according
to manufacturer Mylan
Australia. An emergency
supply of EpiPen Jr
products is being made
available via pharmacies
to patients whose EpiPens
are about to expire, the
company says.
MJA 2017; online.
17 November 2017
|
Australian Doctor
|
3